
Publikationen von M. A. Oberli
Alle Typen
Zeitschriftenartikel (7)
1.
Zeitschriftenartikel
49 (64), S. 7159 - 7161 (2013)
Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine. Chemical Communications 2.
Zeitschriftenartikel
135 (26), S. 9713 - 9722 (2013)
Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope. Journal of the American Chemical Society 3.
Zeitschriftenartikel
18 (5), S. 580 - 588 (2011)
A possible oligosaccharide-conjugate vaccine candidate for Clostridium difficile is antigenic and immunogenic. Chemistry & Biology 4.
Zeitschriftenartikel
193 (14), S. 3506 - 3511 (2011)
Identification of an African Bacillus anthracis lineage that lacks expression of the spore surface-associated anthrose-containing oligosaccharide. Journal of Bacteriology 5.
Zeitschriftenartikel
11 (11), S. 1563 - 1573 (2010)
Determination of carbohydrate-binding preferences of human galectins with carbohydrate microarrays. ChemBioChem: A European Journal of Chemical Biology 6.
Zeitschriftenartikel
132 (30), S. 10239 - 10241 (2010)
Molecular analysis of carbohydrate-antibody interactions: case study using a Bacillus anthracis tetrasaccharide. Journal of the American Chemical Society 7.
Zeitschriftenartikel
26 (22), S. 17143 - 17155 (2010)
Surface characterization of carbohydrate microarrays. Langmuir Buchkapitel (1)
8.
Buchkapitel
Synthetic oigosaccharide bacterial antigens to produce monoclonal antibodies for diagnosis and treatment of disease using Bacillus anthracis as a case study. In: Anticarbohydrate antibodies: from molecular basis to clinical application, S. 37 - 54 (Hg. Kosma, P.; Müller-Loennies, S.). Springer-Verlag, Wien (2012)
Patent (1)
9.
Patent
Oligosaccharides and oligosaccharide-protein conjugates derived from clostridium difficile polysaccharide PS-II, methods of synthesis and uses thereof, in particular as a vaccine. EP2683401 (2012)